Toronto Dominion Bank’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Toronto Dominion Bank’s Portfolio DMAA Stock Details DMAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	100,000 -103,838	-51%	-$1.1M	﹤0.01%	1383
2026 Q1	$2.14M	Buy	203,838 +3,838	+2%	+$40.1K	﹤0.01%	1122
2025 Q4	$2.07M	Sell	200,000 -250,000	-56%	-$2.58M	﹤0.01%	1109
2025 Q3	$4.62M	Sell	450,000 -50,000	-10%	-$513K	0.01%	818
2025 Q2	$5.1M	Sell	500,000 -1,710,100	-77%	-$17.3M	0.01%	747
2025 Q1	$3.47M	Buy	+2,210,100	New	+$22.1M	0.01%	785

Other funds holding DMAA

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Toronto Dominion Bank's DMAA Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Drugs Made In America Acquisition Corp (DMAA) stake by 51% in Q2 2026, selling an estimated $1.1M and leaving 100,000 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Toronto Dominion Bank first reported a position in DMAA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.1M in Q2 2025. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

Toronto Dominion Bank held 100,000 shares of Drugs Made In America Acquisition Corp worth $1.06M as of Q2 2026.
Toronto Dominion Bank sold 103,838 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $1.1M.
Drugs Made In America Acquisition Corp made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1383 holding.
Toronto Dominion Bank first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Toronto Dominion Bank's Drugs Made In America Acquisition Corp position peaked at $5.1M in Q2 2025.
18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.